Aurobindo Pharma Ltd

Aurobindo Pharma Announces ₹800 Crore Share Buyback at ₹1,475 Per Share 📈

• Buyback size: ₹800 crore for up to 54,23,728 equity shares

• Price per share: ₹1,475 (20-21% premium to recent average prices)

• Record date: April 17, 2026 | Buyback period: April 23-29, 2026

• Separate categories for small shareholders (≤144 shares) and general shareholders

• Funded through free reserves – no borrowed funds used

• Post-buyback promoter holding may increase from 51.82% to 51.88%

• Expected to improve EPS and return ratios

• Managed by Axis Capital with KFin Technologies as registrar